{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:51:35Z","timestamp":1792666295848,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vaccine.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T08:26:47Z","timestamp":1622708807000},"page":"3777-3784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein"],"prefix":"10.1016","volume":"39","author":[{"given":"Naoto","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoya","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supasiri","family":"Jarusombuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Masatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.05.002_b0005","doi-asserted-by":"crossref","unstructured":"Zinsstag J, Dushoff J, Cleaveland S, Briggs DJ, Blanton JD, Miranda ME, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 2015;9:e0003709. https:\/\/doi.org\/10.1371\/journal.pntd.0003709.","DOI":"10.1371\/journal.pntd.0003709"},{"key":"10.1016\/j.vaccine.2021.05.002_b0010","unstructured":"World Health Organization. WHO expert consultation on rabies. Third report. World Health Organ Tech Rep Ser; 2018."},{"issue":"1","key":"10.1016\/j.vaccine.2021.05.002_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-014-0077-8","article-title":"Twenty year experience of the oral rabies vaccine SAG2 in wildlife: A global review","volume":"45","author":"M\u00e4hl","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2021.05.002_b0020","first-page":"185","article-title":"Elimination of terrestrial rabies in Western European countries","volume":"119","author":"Cliquet","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2021.05.002_b0025","doi-asserted-by":"crossref","unstructured":"M\u00fcller TF, Schr\u00f6der R, Wysocki P, Mettenleiter TC, Freuling CM. Spatio-temporal use of oral rabies vaccines in fox rabies elimination programmes in Europe. PLoS Negl Trop Dis 2015;9:1\u201316. https:\/\/doi.org\/10.1371\/journal.pntd.0003953.","DOI":"10.1371\/journal.pntd.0003953"},{"issue":"12","key":"10.1016\/j.vaccine.2021.05.002_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2612.201266","article-title":"Role of oral rabies vaccines in the elimination of dog-mediated human rabies deaths","volume":"26","author":"Wallace","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2021.05.002_b0035","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/j.vaccine.2016.08.013","article-title":"Vaccine-induced rabies case in a cow (Bos taurus): Molecular characterisation of vaccine strain in brain tissue","volume":"34","author":"Vuta","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.05.002_b0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/vr.131.3.55","article-title":"Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus)","volume":"131","author":"Bingham","year":"1992","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2021.05.002_b0045","doi-asserted-by":"crossref","DOI":"10.2460\/javma.1979.175.04.376","article-title":"Vaccine-induced rabies in a pet skunk","author":"Debbie","year":"1979","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2021.05.002_b0050","doi-asserted-by":"crossref","DOI":"10.2460\/javma.1982.180.11.1336","article-title":"Vaccine-induced rabies in four cats","author":"Esh","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2021.05.002_b0055","article-title":"Vaccine-induced rabies infection in rural dogs in Anambra State, Nigeria","author":"Okolo","year":"1989","journal-title":"Microbios"},{"issue":"1-3","key":"10.1016\/j.vaccine.2021.05.002_b0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0147-9571(82)90032-7","article-title":"Small mammal studies in a SAD baiting area","volume":"5","author":"Wandeler","year":"1982","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.05.002_b0065","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00705-009-0408-7","article-title":"Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria","volume":"154","author":"M\u00fcller","year":"2009","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.05.002_b0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7589\/2013-07-183","article-title":"Vaccine-induced rabies in a red fox (Vulpes vulpes): Isolation of vaccine virus in brain tissue and salivary glands","volume":"50","author":"Hostnik","year":"2014","journal-title":"J Wildl Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2021.05.002_b0075","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.vaccine.2021.05.002_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13365-015-0350-2","article-title":"Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development","volume":"21","author":"Zhu","year":"2015","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2021.05.002_b0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2015.06.011","article-title":"Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination","volume":"121","author":"Shuai","year":"2015","journal-title":"Antiviral Res"},{"issue":"25-26","key":"10.1016\/j.vaccine.2021.05.002_b0090","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/S0264-410X(01)00064-0","article-title":"Genetic engineering of live rabies vaccines","volume":"19","author":"Morimoto","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2021.05.002_b0095","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2012.03.044","article-title":"Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy","volume":"30","author":"Nakagawa","year":"2012","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2021.05.002_b0100","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1016\/j.vaccine.2017.08.050","article-title":"Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein","volume":"35","author":"Nakagawa","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.002_b0105","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.05.002_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 Gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.05.002_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7774\/cevr.2014.3.2.176","article-title":"A single immunization with recombinant rabies virus (ERAG3G) confers complete protection against rabies in mice","volume":"3","author":"Yang","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"issue":"4","key":"10.1016\/j.vaccine.2021.05.002_b0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern","volume":"12","author":"Lafay","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.05.002_b0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","article-title":"Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice","volume":"172","author":"Tuffereau","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.05.002_b0130","doi-asserted-by":"crossref","unstructured":"Clark HF. Rabies viruses increase in virulence when propagated in neuroblastoma cell culture. Science (80-) 1978;199:1072\u20135. https:\/\/doi.org\/10.1126\/science.628831.","DOI":"10.1126\/science.628831"},{"issue":"4","key":"10.1016\/j.vaccine.2021.05.002_b0135","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.vaccine.2004.06.031","article-title":"In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife","volume":"23","author":"Dietzschold","year":"2004","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2021.05.002_b0140","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.002_b0145","unstructured":"World Health Organization. WHO expert consultation on rabies. second report. World Health Organ Tech Rep Ser; 2013."},{"key":"10.1016\/j.vaccine.2021.05.002_b0150","unstructured":"World Organization for Animal Health (OIE). Rabies (infection with rabies virus and other lyssaviruses). Man. Diagnostic Tests Vaccines Terr. Anim. 2019; 2019, p. 578\u2013612."},{"key":"10.1016\/j.vaccine.2021.05.002_b0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.05.002_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"10.1016\/j.vaccine.2021.05.002_b0165","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1128\/JVI.00787-10","article-title":"Molecular basis of neurovirulence of Flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation","volume":"84","author":"Tao","year":"2010","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:31Z","timestamp":1759402771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21005533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":33,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0264410X21005533"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}